Creatine supplementation does not augment muscle carnosine content in type 2 diabetic patients

about

P921

Creatine supplementation does not augment muscle carnosine content in type 2 diabetic patients

Item

http://www.wikidata.org/entity/Q57537573

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2011

@uk

name

Creatine supplementation does ...... nt in type 2 diabetic patients

@en

Creatine supplementation does ...... nt in type 2 diabetic patients

@nl

type

Item

label

Creatine supplementation does ...... nt in type 2 diabetic patients

@en

Creatine supplementation does ...... nt in type 2 diabetic patients

@nl

prefLabel

Creatine supplementation does ...... nt in type 2 diabetic patients

@en

Creatine supplementation does ...... nt in type 2 diabetic patients

@nl

P1433

Q57537573-9303649A-4254-4541-BDE3-29FEA139DF2A

P1476

Q57537573-64BD4CD8-A289-45F7-804D-1CF00BC73EC5

P2093

Q57537573-51A56D67-8A3D-46FE-8DBD-4FF38971D59D

Q57537573-8A7952FD-2056-449F-859A-33CECAB265C9

Q57537573-909E8BF9-206F-4F79-A4BC-DB045B0FB4D9

Q57537573-AFC56867-0784-4149-B867-4F2DE70F0B5E

Q57537573-C2C3ACC1-193F-4C91-AB39-DBEA3FF75B41

Q57537573-E970B4C2-ED91-4543-BB5B-D56E6181DE8E

Q57537573-F626CE69-9599-4EFC-83CB-E6A54879E629

P2507

Q57537573-6E34F54D-DEC1-4970-8C10-5B23D35D3E05

P2860

Q57537573-05D2985F-A865-41B6-9D3E-E31BF2913CC4

Q57537573-13D464A6-7428-4E82-BC28-E88525950120

Q57537573-1798F340-703B-4C64-A849-0DB157D991C0

Q57537573-445BBE5F-5637-4435-A28B-605624EE0957

Q57537573-4CE18317-88A8-4851-826D-B64CE3A8C231

Q57537573-595E1D5C-3597-4D7A-82B7-ED3DACD45154

Q57537573-6DCD1159-8097-43C6-B554-88EA879427E1

Q57537573-9AB31847-0F75-44F8-8DE8-553440F94D8A

Q57537573-A3717D86-3429-4F96-862A-F4FFEDBA2B86

Q57537573-AA1DB858-A415-4D43-AF2C-1091A7F2C932

P304

Q57537573-41A4D5A7-17C2-4DF6-AF02-7AFB5BEFDFCF

P31

Q57537573-9459C9ED-13E2-438C-B7A6-154637CABA6B

P356

Q57537573-E23E2F04-BEE2-4B08-ABC6-6D38F60FD5B6

P433

Q57537573-82F52232-D530-45A9-80E9-E45CA359B548

P478

Q57537573-C3AC7608-7E11-44D8-8E30-B2BC780003D3

P50

Q57537573-37AAA79F-14D9-46B4-A491-689D0934727D

Q57537573-8328EAEA-2FCD-4C96-8A35-07414AB6A5D8

P577

Q57537573-5C22625A-9AA8-4A99-8A86-E8EFC2CBD04F

P698

Q57537573-9D2F4CD1-FA50-4775-98E2-858A65AB9A19

P356

H11-083

P1433

Applied Physiology, Nutrition, and Metabolism

P1476

Creatine supplementation does ...... nt in type 2 diabetic patients

@en

P2093

Andréia Cristina Carrenho Queiroz

http://www.w3.org/2001/XMLSchema#string

Antonio Herbert Lancha

http://www.w3.org/2001/XMLSchema#string

Cláudia da Costa Leite

http://www.w3.org/2001/XMLSchema#string

Hamilton Roschel

http://www.w3.org/2001/XMLSchema#string

Maria Concepción Otaduy

http://www.w3.org/2001/XMLSchema#string

Rebeca Lugaresi

http://www.w3.org/2001/XMLSchema#string

Vitor Painelli de Salles

http://www.w3.org/2001/XMLSchema#string

P2507

Erratum: Creatine supplementation does not augment muscle carnosine content in type 2 diabetic patients

P2860

Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity.

Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training.

Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.

The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis.

L-carnosine, a substrate of carnosinase-1, influences glucose metabolism.

Creatine supplementation augments skeletal muscle carnosine content in senescence-accelerated mice (SAMP8).

Exploring the therapeutic role of creatine supplementation.

Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats.

Natural histidine-containing dipeptide carnosine as a potent hydrophilic antioxidant with membrane stabilizing function. A biomedical aspect.

Carnosine loading and washout in human skeletal muscles.

P304

764-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/H11-083

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guilherme Giannini Artioli

Bruno Gualano

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21999299

http://www.w3.org/2001/XMLSchema#string